Correlation between selective inhibition of NAD-dependent oxidations and anticonvulsant property of quinazolone allylethers and quinazolone allyphenols.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism; D002951:Citrates / Q000378:metabolism; D004987:Ethers / Q000494:pharmacology; D005260:Female; D005650:Fumarates / Q000378:metabolism; D005971:Glutamates / Q000378:metabolism; D005977:Glutarates / Q000378:metabolism; D006885:Hydroxybutyrates / Q000378:metabolism; D008297:Male; D009243:NAD / Q000378:metabolism*; D010084:Oxidation-Reduction; D010636:Phenols / Q000494:pharmacology; D011799:Quinazolines / Q000494:pharmacology*; D051381:Rats; D013386:Succinates / Q000378:metabolism
D000927:Anticonvulsants; D002951:Citrates; D004987:Ethers; D005650:Fumarates; D005971:Glutamates; D005977:Glutarates; D006885:Hydroxybutyrates; D010636:Phenols; D011799:Quinazolines; D013386:Succinates; D009243:NAD